Acquired resistance to BRAF inhibitory treatments requires tumor tissue remodeling and reveals targetable vulnerabilities in colorectal cancer
Héctor G. Pálmer, Lorena Ramírez, Javier Ros, Oriol Arqués, Jordi Martínez‐Quintanilla, Débora Cabot, Alex Mur-Espinosa, Irene Chicote, Isabel Puig, Gilles Flamen, Ángel de la Torre, Ania Alay, Luna Martín, Raquel Flores, Ariadna García, José Jiménez, Verónica Dávalos, Lara Nonell, Xavier Solé, David P. Kodack, Patrizia Barzaghi-Rinaudo, Lisa Kattenhorn, Slavica Dimitrieva, Paolo Nucíforo, Manel Esteller, Françesc Canals, Ana Vivancos, Diana Graus Porta, Josep Tabernero, Elena Élez (2025). Acquired resistance to BRAF inhibitory treatments requires tumor tissue remodeling and reveals targetable vulnerabilities in colorectal cancer. , DOI: https://doi.org/10.21203/rs.3.rs-6770441/v1.
